Strategic Planning for the Future of Health Care

Project Management Institute


We're happy to help.

Contact Us

Program Information

Program fees include tuition, instructional materials, lodging and 3 meals per day. Airfare, transportation to and from the airport, and personal incidentals are not included.

Related Information

Health care headlines have been dominated by the Affordable Care Act and the implementation of health care exchanges in particular. But long after everything settles, leaders in health care will be faced with new challenges and opportunities, which include:

  • Consumerism
  • Personalized medicine
  • Disruptive innovation
  • Globalization
  • Big Data

Join us as we explore health care now and in the future. Through lectures, global case studies, classroom exercises, small group discussions, and Fuqua faculty's cutting-edge research, you'll be challenged to think more strategically and creatively about how your business can continue to prosper in health care's new landscape.

This program is designed for senior health care professionals (5+ years of work experience) who seek to understand the drivers for healthcare strategy and planning, including but not limited to providers, insurers, service providers, information technology/analytics providers and others who support the delivery of health care.



Day 1

Affordable Care Act (ACA) in 2015 and Beyond looks at how consumers and businesses will respond to the ACA and how Republicans might change the law.

At the end of the session you will:

  • Recognize how changes in reimbursements will impact providers and manufacturers.
  • Identify how challenges in the individual market will vary by small group and employer-sponsored insurance.
  • Understand the Republican proposal and its impact on the ACA.
  • Consider how future generations will receive health care.
Consumerism in Health Care looks at new regulatory and legislative developments, new technologies that close the information gap, and if people can be smart health care consumers.

At the end of the session you will:

  • Be aware of the the choices required for U.S. citizens to purchase health care in the Federal Marketplace.
  • See areas that would benefit from improved cost and quality transparency.
  • Identify unmet needs and opportunities to accelerate consumerism.
 Dinner with Guest Speaker

Day 2

Big Data looks at technological advances in storing and processing data and how firms in the health sector can analyze it to optimize decision making and marketing decisions.

At the end of the session you will:

  • Know how to use data to make decisions in diagnosing and managing disease and conducting clinical trials.
  • Identify how to us big data in forecasting sales and developing a marketing strategy.
  • Be aware of government and private vendor data formats and how to merge them with your data.
  • Plan how to encourage colleagues to analyze, disseminate and implement results.
Disruptive Competition: From Retail Clinics to Biosimilars looks at how low-quality technologies can steal market share and displace incumbents as they evolve.

At the end of the session you will:

  • Understand potential sources of disruptive competition.
  • Have strategies for blocking, partnering, or innovating in your companies.
Mega Trends looks at macroeconomic trends affecting U.S. health care and how the new landscape is creating opportunities and challenges for all stakeholders.

At the end of the session you will:

  • Understand economic, political and social trends influencing the future of U.S. health care.
  • Know how to craft your career and your organization's strategy to leverage and respond to these trends.
Dinner with Guest Speaker

Day 3

Beyond the Blockbuster: Innovation for Niche Markets looks at how drug companies are manufacturing for niche markets and the incentives associated with this trend.

At the end of the session you will:

  • Understand diagnostics and their influence on the market—from blockbuster to stratified and personalized medicine.
  • Recognize how changes in insurance benefit designs are shifting incentives for drug development.
  • Hear from an author of the priority review voucher paper—a law that encourages drug development for neglected and rare pediatric diseases.
Strategic Planning and Wrap Up is time spent discussing which changes are most relevant to you and your organization.

At the end of the session you will:

  • Identify what will be your greatest challenge or opportunity.
  • Describe a strategy in the context of this change.

 Wednesday, May 14

6:45 AM - 9:00 AM
Buffet Breakfast
Executive Dining Room

9:00 AM - 12:00 PM
Affordable Care Act (ACA) in 2015 and Beyond
Donald Taylor / David Ridley

  • Changes in reimbursements
  • Small group vs. employer-sponsored insurance
  • Republican proposal
  • Future generations

12:00 PM - 1:30 PM
Executive Dining Room 

1:30 PM - 4:30 PM
Consumerism in Health Care
Brian Caveney / David Ridley

  • Purchasing health care in the Federal Marketplace
  • Benefits of improved cost and quality transparency
  • Opportunities to accelerate consumerism

6:00 PM - 8:00 PM
Executive Dining Room
Guest Speaker: Dev Sangvai
Accountable Care Organizations

 Thursday, May 15

6:45 AM - 8:30 AM
Buffet Breakfast
Executive Dining Room

8:30 AM - 10:30 AM
Big Data
Guest Speaker - Christian Nimsch

  • Diagnosing and managing disease and conducting clinical trials
  • Forecasting sales and developing a marketing strategy
  • Government vs. private vendor data formats
  • Analyze, disseminate and implement results

10:30 AM - 12:00 PM
Disruptive Competition: From Retail Clinics to Biosimilars
David Ridley

  • Potential sources of disruptive competition
  •  Strategies for blocking, partnering, or innovating

12:00 PM - 1:30 PM
Executive Dining Room 

1:30 PM - 4:30 PM
Mega Trends
Aaron Ronnie Chatterji

  • Economic, political and social trends influencing the future of U.S. health care
  • Strategies to leverage and respond to trends

6:00 PM - 8:00 PM
Executive Dining Room
Guest Speaker: George Abercrombie
Leadership in Health Care

 Friday, May 16

6:45 AM - 8:30 AM
Buffet Breakfast
Executive Dining Room

8:30 AM - 10:30 AM
Beyond the Blockbuster: Innovation for Niche Markets
David Ridley

  • Diagnostics and their influence on the market: Blockbuster, Stratified, and Personalized Medicine
  • Insurance benefit designs shifting incentives for drug development
  • Priority review voucher paper

10:30 AM - 12:00 PM
Strategic Planning and Wrap Up
David Ridley

  • Challenges and opportunities
  • Strategy in the context of change

12:00 PM - 1:30 PM
Executive Dining Room



You'll spend three days with some of Fuqua's world-renowned Health Sector Management faculty who specialize in the field of business and healthcare, a health policy expert from Duke's Sanford School of Public Policy, a chief strategist from SAS Institute's Health & Life Science Division, and a former CEO of Roche Pharmaceuticals, NA. Read their full bios below.

George_Abercrombie_Headshot resizedGeorge B. Abercrombie
Adjunct Professor
Duke University

George served as President and Chief Executive Officer (2011-2009) at Hoffmann-La Roche Incorporated where he was responsible for leading the North American Pharmaceuticals Operations in Nutley, New Jersey, and the Canadian affiliate, Hoffmann-La Roche Ltd. in Mississauga, Ontario. During his tenure, Abercrombie also served as a member of the Roche Pharmaceutical Executive Committee (PEC), which was responsible for developing and implementing global strategy for the Pharmaceuticals Division. While at Roche, Abercrombie was a member of the Executive Committee and Board of Directors of the U.S. trade organization PhRMA (Pharmaceutical Research & Manufacturers of America), and the state Healthcare Institute of New Jersey.

As an Adjunct Professor Abercrombie teaches second year MBA candidates in the Health Sector Management program. Abercrombie currently serves as Chairman of the Board of Brickell Biotech and Vice-Chairman of the Board and Chairman of the Audit Committee of Project Hope. He is Chairman of the Board of Directors of Biocryst Pharmaceuticals where he serves on the Audit, Corporate Governance and Nominating, and Compensation Committees and is a member of the Board of Directors of Physicians Interactive Holdings, Inc.

fs_ronnie resizedAaron “Ronnie” Chatterji

Associate Professor of Strategy
Duke University

From 2010-2011, he served as a Senior Economist at the White House Council of Economic Advisors (CEA) where he worked on a wide range of policies relating to innovation, entrepreneurship, infrastructure and economic growth. His research and teaching investigate some of the most important forces shaping our global economy and society: entrepreneurship, innovation, and the expanding social mission of business. He is especially interested in the fluid boundaries between government and business, and how public policies interact with the activities of responsible companies, social entrepreneurs, and creative customers. He is faculty affiliate of the Health Sector Management program, the Center for Entrepreneurship and Innovation, and the Center for Energy, Development and Global Environment at Duke University.

Nimsch-resizedChristian Nimsch
Chief Strategist
Head of the Center for Health Analytics
SAS Institute's Health & Life Science Division

Launched by SAS in May 2011, the Center for Health Analytics & Insights (CHAI) is a strategic research and incubation group focused on innovation, collaboration and thought leadership aimed at developing scalable applications of advanced analytics across health and life sciences. CHAI is responsible for identifying and responding to emerging opportunities to create novel analytic solutions that help health and life sciences organizations to improve medical care, improve patient outcomes, strengthen financial performance, and create customer insights.

Prior to joining SAS, Christian led patient and provider engagement initiatives that combined market insights, patient and provider education, and multichannel interventions. Across roles, Christian has managed teams of economists, programmers and consulting actuaries to support product value propositions and to develop data driven decision support tools. Christian also has a publication record in peer-reviewed journals in the fields of public health, behavioral research, health-economics and multichannel marketing.

david ridleyDavid Ridley
Faculty Director, Health Sector Management
Dr. and Mrs. Frank A. Riddick Associate Professor of the Practice of Business and Economics
Duke University

In his research, David's examines innovation, location, and pricing, especially in health care. To encourage innovation in medicines for neglected diseases, David, with Henry Grabowski and Jeffrey Moe, proposed a priority review voucher prize. The prize became law in 2007. David teaches courses on health care, economics, and strategy.

donald taylor resizedDonald H. Taylor, Jr.
Associate Professor of Public Policy
Associate Professor of Community and Family Medicine and Nursing Duke University

Don holds three degrees from the University of North Carolina at Chapel Hill, including a PhD in Health Policy and Management from the School of Public Health. He has published numerous peer review articles and co-authored two books. His papers have appeared in the New England Journal of Medicine, BMJ, and Health Affairs, The Journal of the American Geriatrics Society, and Social Science and Medicine. His recent book, Balancing the Budget is a Progressive Priority, poses a next step health reform deal that he says would emerge if both political parties negotiated in policy terms. Most of his ongoing research is in the area of end of life policy with a focus on patient decision making and Medicare hospice policy. He was named a member of the HRSA Negotiated Rulemaking Committee that was created by the Affordable Care Act to reconsider how the federal government identifies Health Professional Shortage Areas and Medically Underserved Areas.

peter ubel resizedPeter Ubel
Associate Faculty Director, Health Sector Management
Physician and Professor of Marketing and Public Policy
Duke University

Peter's research and writing explore the quirks in human nature that influence our lives - the mixture of rational and irrational forces that affect our health, our happiness, and the way our society functions. He explores controversial issues about the role of values and preferences in health care decision making, from decisions at the bedside to policy decisions. Using tools from decision psychology and behavioral economics, he explores topics like informed consent, shared decision making and health care rationing. Visit Peter's personal page for more information.